Position in BMY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,587,315
-$321,825 QoQ
Shares Held
27,548
-12.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#929
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Douglass Winthrop Advisors, LLC holds $62,081,020 across 7 Drug Manufacturers - General names. BMY ranks #4 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
22,774 | $27,315,821 | |
| 2 | JNJ |
Johnson & Johnson
|
104,526 | $26,546,468 | |
| 3 | AMGN |
Amgen Inc
|
8,961 | $3,244,957 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
27,548 | $1,587,315 | |
| 5 | NVS |
Novartis AG
|
8,755 | $1,372,083 | |
| 6 | PFE |
Pfizer Inc
|
52,079 | $1,254,062 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
6,018 | $760,314 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,587,315 | 27,548 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,909,140 | 31,478 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,692,475 | 31,377 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,619,856 | 35,917 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,653,108 | 35,712 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,208,569 | 36,212 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $2,228,294 | 39,397 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,923,693 | 37,180 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,563,687 | 37,652 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $2,278,527 | 42,016 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,407,413 | 46,919 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $2,734,786 | 47,119 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,022,596 | 47,265 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,275,937 | 47,265 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,814,324 | 39,115 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,822,059 | 39,697 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,133,669 | 40,697 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $3,008,616 | 41,197 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,573,122 | 41,269 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,467,448 | 41,701 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $2,496,929 | 37,368 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $2,260,180 | 35,802 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $2,153,495 | 34,717 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $2,138,486 | 35,470 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,382,458 | 40,518 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $2,217,727 | 39,787 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||